Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2005 Sep 22:4:46.
doi: 10.1186/1475-2875-4-46.

A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand

Robert Hutagalung  1 , Lucy Paiphun, Elizabeth A Ashley, Rose McGready, Alan Brockman, Kaw L Thwai, Pratap Singhasivanon, Thomas Jelinek, Nicholas J White, François H Nosten
Affiliations
Randomized Controlled Trial

A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand

Robert Hutagalung et al. Malar J. .

Abstract

Background: The use of antimalarial drug combinations with artemisinin derivatives is recommended to overcome drug resistance in Plasmodium falciparum. The fixed combination of oral artemether-lumefantrine, an artemisinin combination therapy (ACT) is highly effective and well tolerated. It is the only registered fixed combination containing an artemisinin. The trial presented here was conducted to monitor the efficacy of the six-dose regimen of artemether-lumefantrine (ALN) in an area of multi-drug resistance, along the Thai-Myanmar border.

Methods: The trial was an open-label, two-arm, randomized study comparing artemether-lumefantrine and mefloquine-artesunate for the treatment of uncomplicated falciparum malaria with 42 days of follow up. Parasite genotyping by polymerase chain reaction (PCR) was used to distinguish recrudescent from newly acquired P. falciparum infections. The PCR adjusted cure rates were evaluated by survival analysis.

Results: In 2001-2002 a total of 490 patients with slide confirmed uncomplicated P. falciparum malaria were randomly assigned to receive artemether-lumefantrine (n = 245) or artesunate and mefloquine (n = 245) and were followed for 42 days. All patients had rapid initial clinical and parasitological responses. In both groups, the PCR adjusted cure rates by day 42 were high: 98.8% (95% CI 96.4, 99.6%) for artemether-lumefantrine and 96.3% (95% CI 93.1, 98.0%) for artesunate-mefloquine. Both regimens were very well tolerated with no serious adverse events observed attributable to either combination.

Conclusion: Overall, this study confirms that these two artemisinin-based combinations remain highly effective and result in equivalent therapeutic responses in the treatment of highly drug-resistant falciparum malaria.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage of patients with fever (temperature > 37.5°C).
Figure 2
Figure 2
Percentage of patients with positive slide for asexual P. falciparum forms.
Figure 3
Figure 3
Possibly drug-related adverse events (day 1 – day 42).
See this image and copyright information in PMC

References

    1. White NJ. Drug resistance in malaria. Br Med Bull. 1998;54:703–715. - PubMed
    1. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet. 1991;337:1140–1143. doi: 10.1016/0140-6736(91)92798-7. - DOI - PubMed
    1. White NJ. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia. 1999;41:301–308. - PubMed
    1. Looareesuwan S, Olliaro P, White NJ, Chongsuphajaisiddhi T, Sabcharoen A, Thimasarn K, Nosten F, Singhasivanon P, Supavej S, Khusmith S, Wylings S, Kanyok T, Walsh D, Leggat PA, Doberstyn EB. Consensus recommendation on the treatment of malaria in Southeast Asia. Southeast Asian Journal of Tropical Medicine and Public Health. 1998;29:355–360. - PubMed
    1. Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, ter Kuile F, Kham A, Chongsuphajaisiddhi T, White NJ, Nosten F. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg. 1999;60:547–555. - PubMed

Publication types

MeSH terms

LinkOut - more resources